common.study.topics.clinical

Medacta GMK Sphere® Multicenter Post-Market Outcomes Study

common.study.values.description

Medacta GMK Sphere® Multicenter Post-Market Outcomes Study

This study is to average Forgotten Knee Score (FJS) of those patients receiving the Medacta GMK SphereAR knee at the two and five year time points. 70 subjects, enrolled at the data coordinating center in Medacta GMK SphereAR vs Posterior Stabilized study (WIRB Pro Num: 20141994) and randomized to the Sphere arm, will have their data utilized for this study.

common.study.values.location

participant.ui.study.affiliations-map.online-study.header-virtual

participant.ui.study.affiliations-map.online-study.text

participant.ui.study.affiliations-map.legend.locations participant.ui.study.affiliations-map.legend.selected

common.study.values.methods

No pharmaceutical medication involved common.study.methods.has-drugs-no
Patients and healthy individuals accepted common.study.methods.is-healthy-no

Device - Medacta GMK Sphere® Medial Knee Prosthesis

There is no consensus within the Arthroplasty community as to whether a traditional post and cam-style Posterior Stabilized total knee device is superior to a medial-pivot, more congruent device. However, the majority of surgeons seem to prefer the former, though there is a minority that uses the latter device with great success. To date, there have been few prospective trials directly comparing these devices, and none with the latest generation of Total Knee Arthroplasty implants. Almost all su ...read more on ClinicalTrials.org

participant.views.study.view.additional

participant.views.study.view.scientific-title

Medacta GMK Sphere® Medial Pivot, Cruciate Substituting Multicenter, Post-Market Outcomes Study

common.study.values.clinical-trial-id

NCT02501733

participant.views.study.view.id

1aK5Jd